Hide metadata

18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review

dc.date.accessioned2022-03-02T17:35:37Z
dc.date.available2022-03-02T17:35:37Z
dc.date.created2022-01-14T09:56:09Z
dc.date.issued2021
dc.identifier.citationSeierstad, Therese Hole, Knut Håkon Tulipan, Andreas Julius Strømme, Hilde Lilleby, Wolfgang Rootwelt-Revheim, Mona Elisabeth Hernes, Eivor . 18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review. PET Clinics. 2021, 16(2), 167-176
dc.identifier.urihttp://hdl.handle.net/10852/91690
dc.description.abstractAbstract The PET tracer 18F-fluciclovine (Axumin) was recently approved in the United States and Europe for men with suspected prostate cancer recurrence following prior treatment. This article summarizes studies where systematic sector-based histopathology was used as reference standard to assess the diagnostic accuracy of the tracer 18F-fluciclovine PET in patients with prostate cancer.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.title18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
dc.typeJournal article
dc.creator.authorSeierstad, Therese
dc.creator.authorHole, Knut Håkon
dc.creator.authorTulipan, Andreas Julius
dc.creator.authorStrømme, Hilde
dc.creator.authorLilleby, Wolfgang
dc.creator.authorRootwelt-Revheim, Mona Elisabeth
dc.creator.authorHernes, Eivor
cristin.unitcode185,53,63,10
cristin.unitnameAvdeling for radiologi-nukleærmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1980961
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PET Clinics&rft.volume=16&rft.spage=167&rft.date=2021
dc.identifier.jtitlePET Clinics
dc.identifier.volume16
dc.identifier.issue2
dc.identifier.startpage167
dc.identifier.endpage176
dc.identifier.doihttps://doi.org/10.1016/j.cpet.2020.12.012
dc.identifier.urnURN:NBN:no-94305
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn1556-8598
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/91690/1/18F-Fluciclovine-PET-for-Assessment-of-Prostate-Cancer-with-Hist_2021_PET-Cl.pdf
dc.type.versionPublishedVersion


Files in this item

Name:
18F-Fluciclovine-PET-for-Asses ...
Size:
861.1Kb
Format:
application/
View/Open

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International